MedTrace Logo

Feasibility of Endovascular Repair of Ascending Aortic Pathologies

NCT03322033 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2026-03-02

Study results available
· View outcomes & findings →

Summary

The purpose of this early feasibility study is to investigate the outcome of selected patients with ascending thoracic aortic pathologies including type A aortic dissection, who are suitable for endovascular repair with the Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery System (or the Valiant PS-IDE Stent Graft).

Conditions

  • Dissection of Thoracic Aorta

Interventions

DEVICE

Valiant PS-IDE Stent Graft

Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery System

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • William Brinkman, MD · Cardiac Surgery Specialists

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-15
Primary Completion
2021-10-22
Completion
2021-10-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03322033 on ClinicalTrials.gov